InvestorsHub Logo
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

Re: XenaLives post# 8312

Wednesday, 03/06/2019 8:39:12 AM

Wednesday, March 06, 2019 8:39:12 AM

Post# of 21544
The safety profile for Bryostatin is outstanding.

From a peer-reviewed journal (PNAS) article:

"The established clinical safety profile of bryostatin-1 in humans could expedite its development as a therapeutic agent in MS."

If researchers and key opinion leaders are emphasizing Bryostatin's impressive safety profile, why should we doubt them?

https://www.scribd.com/document/386853846/Bryostatin-1-alleviates-experimental-multiple-sclerosis

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News